These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38403131)

  • 21. Inactivation of viruses in labile blood derivatives. I. Disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations.
    Horowitz B; Wiebe ME; Lippin A; Stryker MH
    Transfusion; 1985; 25(6):516-22. PubMed ID: 3934801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Removal of detergent and solvent from solvent-detergent-treated immunoglobulins.
    Trescec A; Simić M; Branović K; Gebauer B; Benko B
    J Chromatogr A; 1999 Aug; 852(1):87-91. PubMed ID: 10480233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A solvent/detergent-treated and 15-nm filtered factor VIII: a new safety standard for plasma-derived coagulation factor concentrates.
    Chtourou S; Porte P; Nogré M; Bihoreau N; Cheesman E; Samor B; Sauger A; Raut S; Mazurier C
    Vox Sang; 2007 May; 92(4):327-37. PubMed ID: 17456157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of manufacturing process parameters on virus inactivation by solvent-detergent treatment in a high-purity factor IX concentrate.
    Roberts PL; Dunkerley C
    Vox Sang; 2003 Apr; 84(3):170-5. PubMed ID: 12670365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sterilisation of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate.
    Prince AM; Horowitz B; Brotman B
    Lancet; 1986 Mar; 1(8483):706-10. PubMed ID: 2870224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress in purification of virus-inactivated factor VIII concentrates. Three generations of solvent/detergent treated plasma derivatives.
    Schwinn H; Smith A; Wolter D
    Arzneimittelforschung; 1989 Oct; 39(10):1302-5. PubMed ID: 2514695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of eco-friendly zwitterionic detergents for enveloped virus inactivation.
    Conley L; Tao Y; Henry A; Koepf E; Cecchini D; Pieracci J; Ghose S
    Biotechnol Bioeng; 2017 Apr; 114(4):813-820. PubMed ID: 27800626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Properties of a concentrated minipool solvent-detergent treated cryoprecipitate processed in single-use bag systems.
    Burnouf T; Caron C; Radosevich M; Goubran HA; Goudemand J; El-Ekiaby M
    Haemophilia; 2008 Sep; 14(5):956-62. PubMed ID: 18565126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. West Nile Virus inactivation by the solvent/detergent steps of the second and third generation manufacturing processes for B-domain deleted recombinant factor VIII.
    Jakubik JJ; Vicik SM; Tannatt MM; Kelley BD
    Haemophilia; 2004 Jan; 10(1):69-74. PubMed ID: 14962223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of Zika virus by solvent/detergent treatment of human plasma and other plasma-derived products and pasteurization of human serum albumin.
    Kühnel D; Müller S; Pichotta A; Radomski KU; Volk A; Schmidt T
    Transfusion; 2017 Mar; 57(3pt2):802-810. PubMed ID: 28019034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Manufacture and in vitro characterization of a solvent/detergent-treated human plasma.
    Hellstern P; Sachse H; Schwinn H; Oberfrank K
    Vox Sang; 1992; 63(3):178-85. PubMed ID: 1448962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoassay-Compatible Inactivation of SARS-CoV-2 in Plasma Samples for Enhanced Handling Safety.
    Liew OW; Fanusi F; Ng JYX; Ahidjo BA; Ling SSM; Lilyanna S; Chong JPC; Lim AES; Lim WZ; Ravindran S; Chu JJH; Lim SL; Richards AM
    ACS Omega; 2022 Jul; 7(29):25510-25520. PubMed ID: 35903176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative removal of solvent and detergent viral inactivating agents from human intravenous immunoglobulin G preparations using SDR HyperD and C18 sorbents.
    Burnouf T; Sayed MA; Radosevich M; El-Ekiaby M
    Anal Biochem; 2009 Jun; 389(1):69-73. PubMed ID: 19303391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing detergent-mediated virus inactivation, protein stability, and impurity clearance in biologics downstream processes.
    Feroz H; Chennamsetty N; Byers S; Holstein M; Li ZJ; Ghose S
    Biotechnol Bioeng; 2022 Apr; 119(4):1091-1104. PubMed ID: 35023152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Removal/neutralization of hepatitis A virus during manufacture of high purity, solvent/detergent factor VIII concentrate.
    Lemon SM; Murphy PC; Smith A; Zou J; Hammon J; Robinson S; Horowitz B
    J Med Virol; 1994 May; 43(1):44-9. PubMed ID: 8083647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of virus in intravenous immunoglobulin G using solvent/detergent treatment and pasteurization.
    Aghaie A; Pourfatollah AA; Bathaie SZ; Moazzeni SM; Khorsand Mohammad Pour H; Sharifi Z
    Hum Antibodies; 2008; 17(3-4):79-84. PubMed ID: 19029665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity.
    Poelsler G; Berting A; Kindermann J; Spruth M; Hämmerle T; Teschner W; Schwarz HP; Kreil TR
    Vox Sang; 2008 Apr; 94(3):184-192. PubMed ID: 18167162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system.
    Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
    Transfusion; 2006 Dec; 46(12):2100-8. PubMed ID: 17176321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma.
    Horowitz B; Bonomo R; Prince AM; Chin SN; Brotman B; Shulman RW
    Blood; 1992 Feb; 79(3):826-31. PubMed ID: 1310064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large-scale purification of high purity α1-antitrypsin from Cohn Fraction IV with virus inactivation by solvent/detergent and dry-heat treatment.
    Huangfu C; Zhang J; Ma Y; Jia J; Li J; Lv M; Ma X; Zhao X; Zhang J
    Biotechnol Appl Biochem; 2018 May; 65(3):446-454. PubMed ID: 29072333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.